PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26141787-8	2015	RESULTS: Functional studies revealed that miR-153 mimic suppresses both glucose- and potassium-induced insulin secretion (GSIS and PSIS, respectively), whereas miR-153 inhibitor enhances both GSIS and PSIS.	Glucose	72-79	microRNA 153	Mus musculus	42-49	
23595248-10	2013	In addition, glucose stimulation, which increases Ia-2 and Ia-2beta expression, also significantly increased expression of miR-153.	Glucose	13-20	microRNA 153	Mus musculus	123-130	
23595248-11	2013	Several predicted targets of miR-153 were reduced after glucose stimulation in vitro, correlating with the increase in miR-153 levels.	Glucose	56-63	microRNA 153	Mus musculus	29-36	
23595248-11	2013	Several predicted targets of miR-153 were reduced after glucose stimulation in vitro, correlating with the increase in miR-153 levels.	Glucose	56-63	microRNA 153	Mus musculus	119-126	
32795559-9	2020	Pancreas overexpression of miR-153 caused glucose intolerance in C57BL/6 J mice but no alterations in body weight or insulin sensitivity.	Glucose	42-49	microRNA 153	Mus musculus	27-34	
32795559-11	2020	Antago-miR-153 treatment ameliorated glucose intolerance in db/db mice during our observation period but did not improve insulin sensitivity.	Glucose	37-44	microRNA 153	Mus musculus	7-14